About MicroTransponder
MicroTransponder is a Healthcare company based in Dallas (United States) founded in 2007 by Navzer Engineer and Jordan Curnes. Neurostimulation for chronic pain management, tinnitus treatment and post-stroke rehabilitation. MicroTransponder has raised $180.45 million across 25 funding rounds from investors including HHS, USVP and Osage University Partners. The company has 33 employees. Its chief executive, as recorded, is Richard Foust. MicroTransponder offers products and services including Vivistim Paired VNS System. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its competitors include Conformal Medical, MIVI Neuroscience and Wallaby Medical; 2 of its 3 listed competitors have raised funding.
Company details
MicroTransponder was founded in 2007 in Dallas, United States, as a spin-out from the University of Texas at Dallas. Medical devices in the neuroscience sector are developed, with operations centered on two neurostimulation platforms. An implanted vagus nerve stimulator is created for tinnitus treatment and post-stroke motor rehabilitation. The wireless SAINT System addresses chronic pain management. Clinical trials are planned to evaluate both platforms for neurological disorders.
- Headquarters Dallas, United States
- Employees 33
- Founders Navzer Engineer, Jordan Curnes
- SectorsHealthcare
- Website microtransponder.com
- Social LinkedIn X Facebook
- Total Equity Funding$180.45M (USD)
in 25 rounds
- Latest Funding Round$65M (USD), Series F
Mar 2025
- InvestorsHHS
& 10 more
- Employee Count33
Products & Services of MicroTransponder
MicroTransponder offers a comprehensive portfolio of products and services, including Vivistim Paired VNS System.
Stimulates vagus nerve during therapy to aid stroke patient motor recovery.
Funding Insights of MicroTransponder
MicroTransponder has successfully raised a total of $180.45M across 25 strategic funding rounds. The most recent funding activity was a Series F round of $65 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $180.45M
- Total Rounds 25
- Last Round Series F — $65M
- First Round $1.38M
(Feb 2008)
- Investors Count 11
Latest 10 of 25 funding rounds of MicroTransponder with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $65M | Series F | – | USVP | |
| Jun 2022 | $73M | Series E | – | USVP | |
| Sep 2020 | $5.75M | Debt – Conventional | – | – | – |
| Nov 2017 | $11.59M | Series C | – | – | – |
| Jun 2017 | $5.53M | Series C | – | – | – |
| Sep 2015 | $5.5M | Series C | – | – | |
| Sep 2013 | $225,043 | Grant | – | – | |
| Feb 2013 | $3.39M | Series C | – | Green Park & Golf Ventures | |
| Jun 2012 | $1.27M | Series B | – | – | – |
| Aug 2011 | Grant | – | – |
11 investors in total: 11 institutional.
Investors in MicroTransponder
MicroTransponder has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, USVP and Osage University Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm that focuses on early stage investments in the US | usvp.com | Menlo Park, United States | ||
Early- to growth-stage startups are targeted for venture capital investments. | oup.vc | Bala Cynwyd, United States | ||
Stage-agnostic investments in US life sciences are pursued. | actionpotentialvc.com | Palo Alto, United States | ||
Early-stage venture capital investments are made in medical startups. | 2011 | gpgventures.com | Dallas, United States | |
Investments in early and late-stage US companies are made. | vertical-group.com | Basking Ridge, United States | ||
Private equity and venture captial firm focused on healthcare sectors | gildehealthcare.com | Cambridge, United States | ||
Private equity firm focused on life science sector | longitudecapital.com | Menlo Park, United States | ||
Exceller Hunt is operated as a family office in Dallas. | excellerhunt.com | Dallas, United States | ||
| uthorizons.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for MicroTransponder
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MicroTransponder
46 people are tracked at MicroTransponder (25 in leadership, 21 in team); the tracked headcount is 33.
| Name | Role | Group |
|---|---|---|
Navzer Engineer | Co-Founder & CSO | Leadership |
Jordan Curnes | Co-Founder & President | Leadership |
Richard Foust | CEO | Leadership |
Brian Carlson | Vice President, Reimbursement & Market Access | Leadership |
Bunker Curnes | Chief Financial Officer | Leadership |
Doug Ellison | Chief Revenue Officer | Leadership |
Klaus L. Dahmen | Vice President of Sales | Leadership |
Rob Hadley | Vice President East | Leadership |
Prashant Rawat | COO | Leadership |
Tyler Sheble | National Market Development Director | Leadership |
John Carrithers | Sr Director, Clinical Affairs | Leadership |
Esther Harjanto | Senior Director Sales Operations | Leadership |
Jason Skubitz | Senior Vice President Engineering And Operations | Leadership |
Chris Snyder | Regional Sales Director - Upper Midwest | Leadership |
Sharon Gilberto | Vice President Of Sales - Midwest | Leadership |
Reema Adham Hinds | Vice President of Research Operations | Leadership |
Julie Lopez | Marketing Director | Leadership |
Natasha Calder | Director, Professional Education | Leadership |
Nate Foreman | Vice President Sales | Leadership |
Jennifer Paradise | Sr. Director Of Marketing | Leadership |
26 more people are available in the full profile.
Complete people profiles for MicroTransponder
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MicroTransponder
3 dated milestones of MicroTransponder across 18 years, from founding to its latest funding, stage changes and deals.
- Founded MicroTransponder is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Series F, of $65.0M.
Competitors of MicroTransponder
MicroTransponder has 3 listed competitors in our database, 2 of them funded. They include Conformal Medical, MIVI Neuroscience and Wallaby Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| conformalmedical.com | 2016 | Nashua, United States | $161M | 29 | Stroke prevention device for atrial fibrillation patients is developed. | |
| mivineuro.com | 2013 | Eden Prairie, United States | $66.48M | 37 | Catheters and devices for acute ischemic stroke treatment are developed. | |
| wallabymedical.com | 2016 | Laguna Hills, United States | 24 | A medical device for stroke treatment is developed. |
Detailed competitors of MicroTransponder
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MicroTransponder
The website of MicroTransponder (microtransponder.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 63.4% vs previous month
Top companies in Neurology
3 companies that operate in the same segment as MicroTransponder (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Microtransponder
Complete news archive for MicroTransponder
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MicroTransponder
MicroTransponder was founded in 2007 and raised its 1st funding round 1 year after it was founded.
MicroTransponder is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Richard Foust is the CEO of MicroTransponder, as recorded in our data.
MicroTransponder is a funded company, having raised a total of $180.45M across 25 funding rounds to date.
MicroTransponder has 33 employees.
MicroTransponder was founded in 2007 in Dallas, United States, as a spin-out from the University of Texas at Dallas. Medical devices in the neuroscience sector are developed, with operations centered on two neurostimulation platforms. An implanted vagus nerve stimulator is created for tinnitus treatment and post-stroke motor rehabilitation. The wireless SAINT System addresses chronic pain management. Clinical trials are planned to evaluate both platforms for neurological disorders.
MicroTransponder's top competitors include Conformal Medical, MIVI Neuroscience and Wallaby Medical.
MicroTransponder offers Vivistim Paired VNS System.
MicroTransponder has 11 investors. Key investors include HHS, USVP, Osage University Partners, Action Potential Venture Capital, and Green Park & Golf Ventures.